Results 11 to 20 of about 66,971 (207)

Fluoroquinolones and Biofilm: A Narrative Review [PDF]

open access: yesPharmaceuticals
Background: Biofilm-associated infections frequently span multiple body sites and represent a significant clinical challenge, often requiring a multidisciplinary approach involving surgery and antimicrobial therapy.
Luzzati, Roberto   +25 more
core   +3 more sources

Repositioning of Fluoroquinolones: A New Approach in Antitumor Therapy. [PDF]

open access: yesBiology (Basel)
Fluoroquinolones are known for their antibacterial properties, but recent research has revealed their potential to inhibit the growth and proliferation of cancer cells.
da Silva JR   +4 more
europepmc   +2 more sources

Fluoroquinolone Mannich bases as promising biologically beneficial molecules [PDF]

open access: yesMinia Journal of Medical Research, 2021
Mannich bases, a structurally heterogeneous aminomethyl functionality, found numerous applicationsin medicinal chemistry field. Fluoroquinolones-Mannich bases here is discussed, with prominence onthe correlation between structure and biological activity ...
Mohamed Abdel-Aziz   +3 more
doaj   +1 more source

Prevalence, risk factors and treatment outcomes of fluoroquinolones-associated tendinopathy in tuberculosis patients at university hospital, Thailand

open access: yesHeliyon, 2023
Background: Tuberculosis (TB) is an epidemic disease in Thailand. Fluoroquinolones are used to treat TB and have a lengthy treatment course. Therefore, many patients may have adverse effects from these medications.
Jirarat Chongboonwatana   +2 more
doaj   +1 more source

Recent Strategies in Design of Antitumor and Antibacterial Fluoroquinolones [PDF]

open access: yesJournal of Advanced Biomedical and Pharmaceutical Sciences, 2021
Fluoroquinolones are known widely used synthetic antibacterial agents. Generally, there were some obstacles associated with their therapeutic use.
Mohamed Samir   +4 more
doaj   +1 more source

Association Between Aortic Aneurysm and Aortic Dissection With Fluoroquinolones Use in Patients With Urinary Tract Infections: A Population‐Based Cohort Study

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Fluoroquinolones are first‐line antibiotics recommended for the treatment of complicated urinary tract infections (UTIs), with frequent reports of adverse effects of aortic aneurysm (AA) and aortic dissection (AD).
Yin‐Yang Chen   +6 more
doaj   +1 more source

Fluoroquinolones’ Biological Activities against Laboratory Microbes and Cancer Cell Lines

open access: yesMolecules, 2022
Development of novel derivatives to rein in and fight bacteria have never been more demanding, as microbial resistance strains are alarmingly increasing.
Ghadeer A. R. Y. Suaifan   +2 more
doaj   +1 more source

The Resistance Mechanism of Mycoplasma bovis From Yaks in Tibet to Fluoroquinolones and Aminoglycosides

open access: yesFrontiers in Veterinary Science, 2022
Mycoplasma bovis (M. bovis) is one of the important pathogens for yaks. Aminoglycosides and fluoroquinolones are frequently used medications for the treatment of M. bovis. Drug-resistant strains were inevitable with the abuse of antibiotics.
Jiaqiang Niu   +5 more
doaj   +1 more source

Transporter and metabolizer gene polymorphisms affect fluoroquinolone pharmacokinetic parameters

open access: yesFrontiers in Pharmacology, 2022
Tuberculosis (TB) is an infectious disease that occurs globally. Treatment of TB has been hindered by problems with multidrug-resistant strains (MDR-TB). Fluoroquinolones are one of the main drugs used for the treatment of MDR-TB.
Nurul Annisa   +5 more
doaj   +1 more source

The incidence of collagen-associated adverse events in pediatric population with the use of fluoroquinolones: a nationwide cohort study in Taiwan

open access: yesBMC Pediatrics, 2020
Background To evaluate the safety of using fluoroquinolones in pediatric population in Taiwan. Methods Patients aged 0~18 years old with fluoroquinolones prescriptions ≥5 consecutive days during year 2000 to 2013 were selected from the National Health ...
Pei-Han Yu   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy